- Home
- HBIO vs GCV Comparison
HBIO vs GCV Comparison
Compare HBIO & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- GCV
- Stock Information
- Founded
- HBIO 1901
- GCV 1988
- Country
- HBIO United States
- GCV United States
- Employees
- HBIO N/A
- GCV N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- GCV Finance/Investors Services
- Sector
- HBIO Industrials
- GCV Finance
- Exchange
- HBIO Nasdaq
- GCV Nasdaq
- Market Cap
- HBIO 93.8M
- GCV 75.8M
- IPO Year
- HBIO 2000
- GCV N/A
- Fundamental
- Price
- HBIO $1.93
- GCV $3.88
- Analyst Decision
- HBIO
- GCV
- Analyst Count
- HBIO 0
- GCV 0
- Target Price
- HBIO N/A
- GCV N/A
- AVG Volume (30 Days)
- HBIO 248.4K
- GCV 57.9K
- Earning Date
- HBIO 03-06-2025
- GCV 01-01-0001
- Dividend Yield
- HBIO N/A
- GCV 13.04%
- EPS Growth
- HBIO N/A
- GCV N/A
- EPS
- HBIO N/A
- GCV N/A
- Revenue
- HBIO $97,732,000.00
- GCV N/A
- Revenue This Year
- HBIO N/A
- GCV N/A
- Revenue Next Year
- HBIO $4.32
- GCV N/A
- P/E Ratio
- HBIO N/A
- GCV N/A
- Revenue Growth
- HBIO N/A
- GCV N/A
- 52 Week Low
- HBIO $1.81
- GCV $3.15
- 52 Week High
- HBIO $4.93
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- HBIO 40.61
- GCV 52.27
- Support Level
- HBIO $1.81
- GCV $3.73
- Resistance Level
- HBIO $2.07
- GCV $3.91
- Average True Range (ATR)
- HBIO 0.13
- GCV 0.09
- MACD
- HBIO -0.01
- GCV 0.01
- Stochastic Oscillator
- HBIO 25.53
- GCV 83.33
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.